Inactive Instrument

Medipharm Labs Corp Stock Toronto S.E.

Equities

CA58504D1006

Pharmaceuticals

Sales 2024 * 43.06M 31.32M Sales 2025 * 58.43M 42.5M Capitalization 30.3M 22.04M
Net income 2024 * -7M -5.09M Net income 2025 * -1M -727K EV / Sales 2024 * 0.7 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 0.52 x
P/E ratio 2024 *
-5 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 97.53%
More Fundamentals * Assessed data
Dynamic Chart
MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5% MT
MediPharm Labs Narrows Q4 Loss, Revenue Grows MT
Transcript : MediPharm Labs Corp., Q4 2023 Earnings Call, Mar 27, 2024
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50% MT
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6% MT
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023 MT
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth MT
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization MT
MediPharm Labs Offers Update on German Cannabis Legalization MT
MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis" MT
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization MT
MediPharm Labs Provides Update on German Cannabis Legalization CI
MediPharm Labs Corp. Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority MT
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority MT
More news
Managers TitleAgeSince
Chief Executive Officer - 22-04-19
Director of Finance/CFO - 21-02-07
President - 18-09-30
Members of the board TitleAgeSince
Director/Board Member 60 23-03-31
Chief Executive Officer - 22-04-19
Director/Board Member - 20-06-21
More insiders
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
More about the company